Literature DB >> 16433941

Decreased corpus callosum size in sickle cell disease: relationship with cerebral infarcts and cognitive functioning.

Jeffrey Schatz1, Robert Buzan.   

Abstract

We assessed midsagittal corpus callosum size in sickle cell disease (SCD) and its relationship to lesion volume, lesion location, and cognitive functioning. Twenty-eight children with SCD and 16 demographic controls completed magnetic resonance imaging (MRI) and neuropsychological testing. Corpus callosum (CC) size was smaller for children with silent infarcts (n = 8) or overt stroke (n = 8) than for those without visible infarcts (n = 12) or control participants. Lesion volume was a robust predictor of IQ and other cognitive scores; total CC size did not typically add explanatory power for these measures. The size of the rostral body of the CC, however, independently predicted measures of distractibility, speeded production, and working memory. Posterior CC size was also decreased among many of the children with SCD, even in the absence of visible infarcts in this region. Brain morphology appears to provide additional information about SCD-related effects on the brain above and beyond visible infarcts.

Entities:  

Mesh:

Year:  2006        PMID: 16433941     DOI: 10.1017/S1355617706060085

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  20 in total

1.  White matter damage in asymptomatic patients with sickle cell anemia: screening with diffusion tensor imaging.

Authors:  B Sun; R C Brown; L Hayes; T G Burns; J Huamani; D J Bearden; R A Jones
Journal:  AJNR Am J Neuroradiol       Date:  2012-05-17       Impact factor: 3.825

2.  Positive correlations between corpus callosum thickness and intelligence.

Authors:  Eileen Luders; Katherine L Narr; Robert M Bilder; Paul M Thompson; Philip R Szeszko; Liberty Hamilton; Arthur W Toga
Journal:  Neuroimage       Date:  2007-07-12       Impact factor: 6.556

Review 3.  Targeting pain at its source in sickle cell disease.

Authors:  Kanika Gupta; Om Jahagirdar; Kalpna Gupta
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-03-28       Impact factor: 3.619

4.  Does Obstructive Sleep Apnea Increase Cognitive Deficits in Pediatric Sickle Cell Disease?

Authors:  Sarah E Bills; Tal Katz; Jaleel McNeil; Jeffrey Schatz
Journal:  J Int Neuropsychol Soc       Date:  2019-07-30       Impact factor: 2.892

Review 5.  Hypoxic adaptation during development: relation to pattern of neurological presentation and cognitive disability.

Authors:  Fenella J Kirkham; Avijit K Datta
Journal:  Dev Sci       Date:  2006-07

6.  The link between callosal thickness and intelligence in healthy children and adolescents.

Authors:  Eileen Luders; Paul M Thompson; Katherine L Narr; Alen Zamanyan; Yi-Yu Chou; Boris Gutman; Ivo D Dinov; Arthur W Toga
Journal:  Neuroimage       Date:  2010-10-13       Impact factor: 6.556

7.  Anemia predicts lower white matter volume and cognitive performance in sickle and non-sickle cell anemia syndrome.

Authors:  Soyoung Choi; Sharon H O'Neil; Anand A Joshi; Jian Li; Adam M Bush; Thomas D Coates; Richard M Leahy; John C Wood
Journal:  Am J Hematol       Date:  2019-07-23       Impact factor: 10.047

8.  Neuroimaging abnormalities in adults with sickle cell anemia: associations with cognition.

Authors:  R Scott Mackin; Philip Insel; Diana Truran; Elliot P Vichinsky; Lynne D Neumayr; F D Armstrong; Jeffrey I Gold; Karen Kesler; Joseph Brewer; Michael W Weiner
Journal:  Neurology       Date:  2014-02-12       Impact factor: 9.910

9.  Working Memory in Children With Neurocognitive Effects From Sickle Cell Disease: Contributions of the Central Executive and Processing Speed.

Authors:  Kelsey E Smith; Jeffrey Schatz
Journal:  Dev Neuropsychol       Date:  2016-10-19       Impact factor: 2.253

10.  Quantification of white matter injury following neonatal stroke with serial DTI.

Authors:  Niek E van der Aa; Frances J Northington; Brian S Stone; Floris Groenendaal; Manon J N L Benders; Giorgio Porro; Shoko Yoshida; Susumu Mori; Linda S de Vries; Jiangyang Zhang
Journal:  Pediatr Res       Date:  2013-03-11       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.